$PHM
PULTEGROUP INC/MI/

2023 Q4 Form 10-Q Financial Statement

#000082241623000042 Filed on October 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $4.294B $4.004B
YoY Change -16.97% 1.51%
Cost Of Revenue $3.044B $2.775B
YoY Change -17.14% 0.63%
Gross Profit $1.250B $1.229B
YoY Change -16.56% 3.57%
Gross Profit Margin 29.1% 30.7%
Selling, General & Admin $308.3M $353.2M
YoY Change -12.12% 0.87%
% of Gross Profit 24.67% 28.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $21.06M $20.56M
YoY Change 10.93% 10.89%
% of Gross Profit 1.69% 1.67%
Operating Expenses $309.1M $353.2M
YoY Change -12.14% 0.87%
Operating Profit $940.5M $875.8M
YoY Change -17.92% 4.7%
Interest Expense $19.92M $20.07M
YoY Change -59.46% 2572.97%
% of Operating Profit 2.12% 2.29%
Other Income/Expense, Net $16.73M
YoY Change -166.4%
Pretax Income $946.8M $847.3M
YoY Change -18.65% 4.44%
Income Tax $235.8M $208.5M
% Of Pretax Income 24.91% 24.61%
Net Earnings $708.5M $638.8M
YoY Change -19.21% 1.73%
Net Earnings / Revenue 16.5% 15.96%
Basic Earnings Per Share $2.92
Diluted Earnings Per Share $3.29 $2.90
COMMON SHARES
Basic Shares Outstanding 215.6M shares 219.4M shares
Diluted Shares Outstanding 219.7M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.807B $1.848B
YoY Change 71.55% 699.15%
Cash & Equivalents $1.807B $1.848B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $11.80B $11.59B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $13.60B $13.43B
YoY Change 9.88% 11.91%
LONG-TERM ASSETS
Property, Plant & Equipment $221.5M $69.90M
YoY Change 10.6% 0.87%
Goodwill $68.93M $68.93M
YoY Change 0.0%
Intangibles $56.34M
YoY Change -58.52%
Long-Term Investments $166.9M $162.3M
YoY Change 13.69% 2.66%
Other Assets $131.2M $152.1M
YoY Change -21.0% -26.26%
Total Long-Term Assets $2.485B $2.283B
YoY Change 2.8% 3.44%
TOTAL ASSETS
Total Short-Term Assets $13.60B $13.43B
Total Long-Term Assets $2.485B $2.283B
Total Assets $16.09B $15.72B
YoY Change 8.72% 10.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $619.0M $567.6M
YoY Change 9.37% -5.31%
Accrued Expenses $1.583B $1.629B
YoY Change -0.2% 2.63%
Deferred Revenue
YoY Change
Short-Term Debt $499.6M $425.5M
YoY Change -14.84% 25.8%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.377B $3.392B
YoY Change -4.14% -3.21%
LONG-TERM LIABILITIES
Long-Term Debt $1.962B $1.981B
YoY Change -4.07% -16.19%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.962B $1.981B
YoY Change -4.07% -16.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.377B $3.392B
Total Long-Term Liabilities $1.962B $1.981B
Total Liabilities $5.704B $5.705B
YoY Change -3.04% -5.67%
SHAREHOLDERS EQUITY
Retained Earnings $7.013B
YoY Change 25.64%
Common Stock $2.126M
YoY Change -5.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.38B $10.01B
YoY Change
Total Liabilities & Shareholders Equity $16.09B $15.72B
YoY Change 8.72% 10.59%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $708.5M $638.8M
YoY Change -19.21% 1.73%
Depreciation, Depletion And Amortization $21.06M $20.56M
YoY Change 10.93% 10.89%
Cash From Operating Activities $288.4M $457.8M
YoY Change -70.34% -212.67%
INVESTING ACTIVITIES
Capital Expenditures $24.64M $22.49M
YoY Change 2.34% -186.39%
Acquisitions
YoY Change
Other Investing Activities -$9.424M -$18.55M
YoY Change -234.19% 235.93%
Cash From Investing Activities -$34.06M -$41.04M
YoY Change 99.75% 30.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -304.7M -294.9M
YoY Change 100.24% 10112.78%
NET CHANGE
Cash From Operating Activities 288.4M 457.8M
Cash From Investing Activities -34.06M -41.04M
Cash From Financing Activities -304.7M -294.9M
Net Change In Cash -50.38M 121.8M
YoY Change -106.27% -127.63%
FREE CASH FLOW
Cash From Operating Activities $288.4M $457.8M
Capital Expenditures $24.64M $22.49M
Free Cash Flow $263.8M $435.3M
YoY Change -72.18% -214.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Dividends
Dividends
34624000 usd
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
180446000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
8164003000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
7489515000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6030000 usd
us-gaap Dividends
Dividends
106650000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
14325000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28975000 usd
us-gaap Net Income Loss
NetIncomeLoss
1735086000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
45000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
8164003000 usd
us-gaap Net Income Loss
NetIncomeLoss
1891379000 usd
us-gaap Net Income Loss
NetIncomeLoss
1735086000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
132389000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1833565000 usd
CY2022Q3 phm Write Off Of Deposits And Pre Acquisition Costs
WriteOffOfDepositsAndPreAcquisitionCosts
24462000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2623000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2766000 usd
CY2022Q3 us-gaap Interest Income Other
InterestIncomeOther
370000 usd
CY2023Q3 us-gaap Interest Expense Other
InterestExpenseOther
120000 usd
CY2022Q3 us-gaap Interest Expense Other
InterestExpenseOther
65000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2625000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1283000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16729000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25640000 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
34400000 usd
CY2023Q3 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
19118000 usd
CY2023Q3 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
15238000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
638775000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
627928000 usd
CY2023Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
121000 usd
CY2022Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
202000 usd
CY2023Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
2083000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
624192000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218288000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
230967000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1394000 shares
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
362000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
362000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16729000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25640000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
32134000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-33220000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
847314000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
811277000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2502449000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2275743000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
208539000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
183349000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
611070000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
540657000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
638775000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
627928000 usd
us-gaap Net Income Loss
NetIncomeLoss
1891379000 usd
us-gaap Net Income Loss
NetIncomeLoss
1735086000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.92
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.70
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.26
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.90
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.22
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.48
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218288000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
230967000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
221832000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
237639000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1394000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1333000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1152000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1240000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219682000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
232300000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222984000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
238879000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
638775000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
627928000 usd
us-gaap Net Income Loss
NetIncomeLoss
1891379000 usd
us-gaap Net Income Loss
NetIncomeLoss
1735086000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
45000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
45000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
638775000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
627928000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1891379000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1735131000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
9705025000 usd
CY2023Q3 us-gaap Dividends
Dividends
35020000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
300000000 usd
CY2023Q3 phm Excise Tax On Share Repurchase
ExciseTaxOnShareRepurchase
-3000000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
20000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6741000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
638775000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
10012501000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4842000 usd
us-gaap Dividends
Dividends
106792000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
700000000 usd
phm Excise Tax On Share Repurchase
ExciseTaxOnShareRepurchase
6701000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10408000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26083000 usd
us-gaap Net Income Loss
NetIncomeLoss
1891379000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
10012501000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
711000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6640000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
627928000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
974673000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
43485000 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
16978000 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
32475000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
362000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
59765000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
51934000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4348000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2390000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4564000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1278000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
38401000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
39520000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
501000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-952000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
173377000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2706142000 usd
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-262637000 usd
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-507861000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
142131000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
127173000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-177050000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
119189000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1908344000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-303925000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
67561000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88585000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
18059000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
58154000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
2316000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
3413000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
10400000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
11727000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
964000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-95031000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-154690000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
86794000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4856000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1925000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1606000000 usd
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-161254000 usd
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-287933000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1500000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
11167000 usd
phm Proceeds Land Under Purchase Options Recorded
ProceedsLandUnderPurchaseOptionsRecorded
108707000 usd
phm Proceeds Land Under Purchase Options Recorded
ProceedsLandUnderPurchaseOptionsRecorded
0 usd
phm Payments Land Under Purchase Options Recorded
PaymentsLandUnderPurchaseOptionsRecorded
49379000 usd
phm Payments Land Under Purchase Options Recorded
PaymentsLandUnderPurchaseOptionsRecorded
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
700000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10409000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14326000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
107676000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
109597000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1008305000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1083552000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
805008000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1542167000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1094553000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1899561000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
291398000 usd
phm Interestpaidcapitalizednet
Interestpaidcapitalizednet
11048000 usd
phm Interestpaidcapitalizednet
Interestpaidcapitalizednet
5642000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
546871000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
493559000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective with our first quarter 2023 reporting, we reclassified our closing cost incentives provided to customers, including seller-paid financing costs, from home sale cost of revenues to home sale revenues. All prior period amounts have been reclassified to conform to the current presentation. As a result, all sales incentives provided to customers are classified as a reduction of home sale revenues. This reclassification had the effect of reducing both home sale revenues and home sale cost of revenues by the amount of such closing cost incentives, which totaled $48.8 million and $133.3 million for the three and nine months ended September 30, 2022, respectively.</span></div>
CY2023Q3 phm Write Off Of Deposits And Pre Acquisition Costs
WriteOffOfDepositsAndPreAcquisitionCosts
2456000 usd
phm Write Off Of Deposits And Pre Acquisition Costs
WriteOffOfDepositsAndPreAcquisitionCosts
9629000 usd
phm Write Off Of Deposits And Pre Acquisition Costs
WriteOffOfDepositsAndPreAcquisitionCosts
32475000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7915000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8353000 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
19303000 usd
us-gaap Interest Income Other
InterestIncomeOther
41701000 usd
us-gaap Interest Income Other
InterestIncomeOther
1048000 usd
us-gaap Interest Expense Other
InterestExpenseOther
347000 usd
us-gaap Interest Expense Other
InterestExpenseOther
216000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8324000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6776000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
32134000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-33220000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
769900000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
783600000 usd
CY2023Q3 phm Contractassetinsurancerenewals
Contractassetinsurancerenewals
70600000 usd
CY2022Q4 phm Contractassetinsurancerenewals
Contractassetinsurancerenewals
57300000 usd
CY2023Q3 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
414400000 usd
CY2022Q4 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
677200000 usd
CY2023Q3 us-gaap Inventory Real Estate Mortgage Loans Held In Inventory
InventoryRealEstateMortgageLoansHeldInInventory
423200000 usd
CY2022Q4 us-gaap Inventory Real Estate Mortgage Loans Held In Inventory
InventoryRealEstateMortgageLoansHeldInInventory
680500000 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
33700000 usd
us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
102800000 usd
us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
131900000 usd
us-gaap Maximum Length Of Time Hedged In Cash Flow Hedge1
MaximumLengthOfTimeHedgedInCashFlowHedge1
P90D
CY2022Q4 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
15780000 usd
CY2022Q4 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
22590000 usd
us-gaap Net Income Loss
NetIncomeLoss
1891379000 usd
us-gaap Net Income Loss
NetIncomeLoss
1735086000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
369000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
635000 usd
CY2022Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
3534000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
6685000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
10288000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
636571000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1884325000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1724163000 usd
CY2023Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
2083000 usd
CY2022Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
3534000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
6685000 usd
CY2023Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
2066000 usd
CY2022Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
3508000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
6636000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
10218000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
636588000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
221832000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
237639000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1333000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1152000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1240000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219682000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
232300000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222984000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
238879000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.92
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.70
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.26
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.90
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.22
us-gaap Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts
FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
Credit lossesWe are exposed to credit losses primarily through our vendors and insurance carriers. We assess and monitor each counterparty’s ability to pay amounts owed by considering contractual terms and conditions, the counterparty’s financial condition, macroeconomic factors, and business strategy.
CY2023Q3 phm Assets In Scope Under Accounting Standards Codification326
AssetsInScopeUnderAccountingStandardsCodification326
207200000 usd
CY2022Q4 phm Assets In Scope Under Accounting Standards Codification326
AssetsInScopeUnderAccountingStandardsCodification326
222900000 usd
CY2023Q3 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
5355403000 usd
CY2022Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
5440186000 usd
CY2023Q3 us-gaap Land Available For Development
LandAvailableForDevelopment
5519982000 usd
CY2022Q4 us-gaap Land Available For Development
LandAvailableForDevelopment
5134432000 usd
CY2023Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
573726000 usd
CY2022Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
679341000 usd
CY2023Q3 phm Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
136336000 usd
CY2022Q4 phm Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
72058000 usd
CY2023Q3 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
11585447000 usd
CY2022Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
11326017000 usd
CY2023Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
141994000 usd
CY2022Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
151554000 usd
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
137262000 usd
CY2021Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
160756000 usd
CY2023Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
31659000 usd
CY2022Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
33235000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
95388000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
96156000 usd
CY2023Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
33643000 usd
CY2022Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
41120000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
92640000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
113243000 usd
CY2023Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
140010000 usd
CY2022Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
143669000 usd
CY2023Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
140010000 usd
CY2022Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
143669000 usd
CY2023Q3 us-gaap Purchase Options Land
PurchaseOptionsLand
611458000 usd
CY2023Q3 phm Remaining Purchase Price Of All Land Option Agreements
RemainingPurchasePriceOfAllLandOptionAgreements
6257651000 usd
CY2022Q4 us-gaap Purchase Options Land
PurchaseOptionsLand
478755000 usd
CY2022Q4 phm Remaining Purchase Price Of All Land Option Agreements
RemainingPurchasePriceOfAllLandOptionAgreements
5400241000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
6 segment
CY2023Q3 us-gaap Revenues
Revenues
4003533000 usd
CY2022Q3 us-gaap Revenues
Revenues
3895062000 usd
us-gaap Revenues
Revenues
11767926000 usd
us-gaap Revenues
Revenues
10924333000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
847314000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
811277000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2502449000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2275743000 usd
CY2023Q3 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
6868000 usd
CY2022Q3 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
24462000 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
16978000 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
32475000 usd
CY2023Q3 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
5355403000 usd
CY2023Q3 us-gaap Land Available For Development
LandAvailableForDevelopment
5519982000 usd
CY2023Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
573726000 usd
CY2023Q3 phm Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
136336000 usd
CY2023Q3 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
11585447000 usd
CY2023Q3 us-gaap Assets
Assets
15717263000 usd
CY2022Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
5440186000 usd
CY2022Q4 us-gaap Land Available For Development
LandAvailableForDevelopment
5134432000 usd
CY2022Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
679341000 usd
CY2022Q4 phm Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
72058000 usd
CY2022Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
11326017000 usd
CY2022Q4 us-gaap Assets
Assets
14796515000 usd
CY2023Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
8465000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
9701000 usd
CY2023Q3 us-gaap Senior Notes
SeniorNotes
1926535000 usd
CY2022Q4 us-gaap Senior Notes
SeniorNotes
1990299000 usd
CY2023Q3 us-gaap Other Notes Payable
OtherNotesPayable
54780000 usd
CY2022Q4 us-gaap Other Notes Payable
OtherNotesPayable
55228000 usd
CY2022Q4 us-gaap Other Notes Payable
OtherNotesPayable
55228000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
1981315000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
2045527000 usd
CY2023Q3 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
1998032000 usd
CY2022Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
2079218000 usd
CY2023Q3 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
1300000000 usd
CY2023Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1800000000 usd
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
945400000 usd
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
303400000 usd
CY2022Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
946600000 usd
us-gaap Dividends
Dividends
106800000 usd
us-gaap Dividends
Dividends
106700000 usd
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.246
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.226
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.238
CY2023Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
265500000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
133100000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
58700000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23600000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
5700000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
4100000 usd
CY2023Q3 us-gaap Other Notes Payable
OtherNotesPayable
54780000 usd
CY2022Q4 us-gaap Other Notes Payable
OtherNotesPayable
55228000 usd
CY2022Q4 us-gaap Other Notes Payable
OtherNotesPayable
55228000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
110605000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
108348000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
107117000 usd
CY2023Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
304600000 usd
CY2023Q3 phm Surety Bonds Outstanding
SuretyBondsOutstanding
2300000000 usd
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
303400000 usd
CY2022Q4 phm Surety Bonds Outstanding
SuretyBondsOutstanding
2200000000 usd
CY2023Q3 phm Comprehensive Limited Warranty Against Building Defects
ComprehensiveLimitedWarrantyAgainstBuildingDefects
P1Y
phm Maximum Product Warranty In Years
MaximumProductWarrantyInYears
P10Y
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
106136000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
29412000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
22840000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
74598000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
66398000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
24984000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
23137000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
75313000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
65466000 usd
CY2023Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1747000 usd
CY2022Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
24000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
4678000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
2283000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
112311000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
110332000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
112311000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
110332000 usd
CY2023Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
623000000 usd
CY2022Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
635900000 usd
CY2022Q4 phm Incurred But Not Reported Percentage Of Liability Reserves
IncurredButNotReportedPercentageOfLiabilityReserves
0.74
CY2023Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
605192000 usd
CY2022Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
652686000 usd
CY2022Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
635857000 usd
CY2021Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
627067000 usd
CY2023Q3 phm Additions To Self Insurance Reserves
AdditionsToSelfInsuranceReserves
20578000 usd
CY2022Q3 phm Additions To Self Insurance Reserves
AdditionsToSelfInsuranceReserves
31134000 usd
phm Additions To Self Insurance Reserves
AdditionsToSelfInsuranceReserves
70050000 usd
phm Additions To Self Insurance Reserves
AdditionsToSelfInsuranceReserves
74676000 usd
CY2023Q3 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-789000 usd
CY2022Q3 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-2169000 usd
us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-66209000 usd
us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
1889000 usd
CY2023Q3 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
2000000 usd
CY2022Q3 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
2358000 usd
us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
16717000 usd
us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
24339000 usd
CY2023Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
622981000 usd
CY2022Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
679293000 usd
CY2023Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
622981000 usd
CY2022Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
679293000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
69900000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
84800000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
73500000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
90100000 usd
CY2023Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1300000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9600000 usd
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3300000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7500000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
6100000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
17400000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
5000000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
16100000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
13500000 usd
us-gaap Lease Cost
LeaseCost
42000000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
14300000 usd
us-gaap Lease Cost
LeaseCost
40500000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
2700000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
8900000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
3300000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
7700000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
12800000 usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5200000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
15800000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9235000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
25010000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
17320000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12885000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10240000 usd
CY2023Q3 phm Lessee Operating Lease Liabilitytobe Paidafter Year Four
LesseeOperatingLeaseLiabilitytobePaidafterYearFour
17256000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
91946000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7147000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
84799000 usd
CY2023Q3 phm Lessee Operating Lease Lease Not Yet Commenced Liability
LesseeOperatingLeaseLeaseNotYetCommencedLiability
6200000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y9M18D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
phm-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
phm-20230930_def.xml Edgar Link unprocessable
0000822416-23-000042-index-headers.html Edgar Link pending
0000822416-23-000042-index.html Edgar Link pending
0000822416-23-000042.txt Edgar Link pending
0000822416-23-000042-xbrl.zip Edgar Link pending
exhibit31aceocertification.htm Edgar Link pending
exhibit31bcfocertification.htm Edgar Link pending
exhibit32-certification093.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
phm-20230930.htm Edgar Link pending
phm-20230930.xsd Edgar Link pending
phm-20230930_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
phm-20230930_lab.xml Edgar Link unprocessable
phm-20230930_pre.xml Edgar Link unprocessable
phm-20230930_htm.xml Edgar Link completed